BP001441-PRO-661: Recombinant Human Fatty acid-binding protein 7 (FABP7), His Tag
Source: E. coli-derived.
Purity: > 95.0% by SDS-PAGE.BP001440-PRO-649: Recombinant Human Fatty Acid-Binding Protein 6 (FABP6)
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP001439-PRO-417: Recombinant Human Fatty Acid-Binding Protein 5 (FABP5)
Source: E. coli-derived.
Applications: Western blotting, ELISA.
Purity: > 90% by SDS PAGE.BP001438-PRO-668: Recombinant Human Fatty acid-binding protein 3 (FABP3), His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP001438-PRO-340: Recombinant Human Fatty acid-binding protein 3 (FABP3)
Source: E. coli-derived.
Purity: > 90.0% by RP-HPLC and SDS-PAGE.BP001437-PRO-669: Recombinant Human Fatty Acid-Binding Protein 2 (FABP2)
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP001436-PRO-1121: Recombinant Mouse Fatty acid-binding protein 1 (FABP1)
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP001436-PRO-588: Recombinant Human Fatty acid-binding protein 1 (FABP1)
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000595-ENZ-447: Recombinant Human Esterase D (ESD) Enzyme
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000972-PKA-342: Recombinant Human Tyrosine Kinase ErbB-3
Source: E. coli-derived.
Measured by its ability to postpone tumor emerge time of spontaneous breast cancer in FVB/N transgenic mice and inhibit the development of tumor, effectively inhibit the growth of in situ transplanted breast cancer in FVB/N transgenic mice.
Purity > 95%, by RP-HPLC and SDS-PAGE.